VAERS reports by lot

Pfizer COVID-19 lot NA4452: VAERS reports

86 VAERS reports list lot NA4452 as a Pfizer COVID-19 vaccine, received between 2025-10-04 and 2026-03-22. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
86
Reports
6%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction6528%
Neurological4419%
General / Systemic (non-local)3616%
Musculoskeletal219%
Cardiac / Cardiovascular177%
Dermatological (non-injection-site)177%
Respiratory104%
Allergic / Anaphylactic63%
Gastrointestinal63%
Psychiatric / Neuropsychiatric42%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California10
Florida9
Massachusetts7
North Carolina6
Virginia6
New York5
South Carolina3
Nevada3
Maryland3
Maine3
Pennsylvania3
Minnesota3

Reports by month received

MonthReportsBar
2025-1049
2025-1118
2025-1213
2026-013
2026-021
2026-032

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): NA0738 · NA0739 · NA0846 · NA4457 · NA4459 · NE4289

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.